In Scotland, only 60.4% of clinically vulnerable 5 – 64 year-olds have 3 https://www.biorxiv.org/content/10.1101/2022.09.15.507787v4 4 https://www.biorxiv.org/content/10.1101/2022.11.17.516888v2 5 https://bloodcancer.org.uk/news/evusheld-does-it-work-against-omicron/ 6 https://www.covid19treatmentguidelines.nih.gov/overview/prevention-of-sars-cov-2/ 7 https://aacrjournals.org/bloodcancerdiscov/article/doi/10.1158/2643-3230.BCD-22-0077/709472/Anti-spike-T-cell-and- Antibody-Responses-to-SARS had their autumn booster (as of 7 December, according to PHS).